| EPB098 | Impact of HCV treatment on markers of kidney disease among persons with monoinfection and HCV/HIV co-infection | E-poster | Renal disease |
| EPB097 | The effect of an HIV pharmacist on cardiovascular risk assessment in a regional HIV clinic: a cohort study | E-poster | Cardiovascular disease |
| EPB096 | Arterial remodeling is associated with CD4 T cell count and plasma IL-10 in persons with HIV | E-poster | Cardiovascular disease |
| EPB095 | Silent coronary heart disease in patients on ART: prevalence and risk factors | E-poster | Cardiovascular disease |
| EPB094 | Lp(a) in people living with HIV | E-poster | Cardiovascular disease |
| EPB093 | IL-32 isoforms differentially impact coronary artery endothelium functions and potential to recruit inflammatory cells | E-poster | Cardiovascular disease |
| EPB092 | Cardiovascular disease risk in transgender and cisgender women living with and without HIV | E-poster | Cardiovascular disease |
| EPB091 | Evaluation of screening algorithms based on HPV testing with partial genotyping for the prevention of cervical cancer among HIV-infected women in resource-limited countries: results of the ANRS 12375 study | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB090 | Kaposi sarcoma in ART-treated PLWH and HIV-uninfected people: differences in viral and immune characteristics | E-poster | Malignancies (AIDS and non-AIDS) |
| EPB089 | Persistent low-level viremia may increase the risk of cancer in people living with HIV | E-poster | Malignancies (AIDS and non-AIDS) |